Exacerbation and Training in Patients With Chronic Obstructive Pulmonary Disease
EXTRA
Exacerbation and Training - Study; a Randomized Controlled Study of the Effect of Resistance Training in Acute Exacerbations of COPD
1 other identifier
interventional
40
1 country
1
Brief Summary
When patients with chronic obstructive lung disease (COPD) are admitted to the hospital with a severe exacerbation they lose muscle strength. This muscle weakness predisposes these patients to further hospital admissions. Resistance training is a potent countermeasure to prevent and treat muscle weakness. In the setting of an acute exacerbation this intervention however has not been validated. The present study aims at investigating the safety and efficacy of resistance training (3x8 quadriceps extensions per day) to prevent muscle weakness. End points are quadriceps muscle strength and hospital readmission and functional status at discharge. Using the minimally invasive needle muscle biopsy technique described by Bergström the effects of resistance training on the skeletal muscle will be analyzed in detail. After giving informed consent, patients will be randomized on admission into usual care or usual care plus resistance training. Patients will be followed-up using the clinical pathway for COPD (10 days). After one month patients will attend the outpatient clinic for a follow-up visit. Besides the measurement prescribed in the clinical path for COPD (including arterial blood gas measures, lung function, functional investigation of the patients), patients will undergo muscle strength measures and venous blood will be drawn for the analysis of systemic inflammatory and growth factors. Half of the patients will receive a resistance training program. At the end of the hospital admission, a needle biopsy of the vastus lateralis muscle will be obtained.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2004
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
April 6, 2009
CompletedFirst Posted
Study publicly available on registry
April 7, 2009
CompletedApril 7, 2009
April 1, 2009
1.9 years
April 6, 2009
April 6, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reduction in the decline of muscle force during the exacerbation.
discharge Day 9
Secondary Outcomes (4)
Time to readmission or death
6 Months
Functional exercise capacity at discharge (6MWT)
discharge Day 9
Functional exercise capacity and muscle force at 1 month
1 Month
Markers of systemic inflammation and oxidative stress in serum and muscle of patients at day 9 of the exacerbation.
Day 9
Study Arms (2)
1
EXPERIMENTALResistance training: series of 3x8 repetitions will be performed for the quadriceps muscle at 70% of the 1 Repetition Maximum determined as the weight the patient can lift once over the full range of motion. The weight can be applied using free weights or using a classical multi-gym device or a quadriceps chair.
2
PLACEBO COMPARATORUsual care according to clinical pathway for COPD exacerbations + NO training
Interventions
Resistance training: series of 3x8 repetitions will be performed for the quadriceps muscle at 70% of the 1 Repetition Maximum determined as the weight the patient can lift once over the full range of motion. The weight can be applied using free weights or using a classical multi-gym device or a quadriceps chair.
Eligibility Criteria
You may qualify if:
- COPD exacerbation, admitted to the respiratory units
- Informed consent
- Age \< 80
- No critical comorbidity compromising outcome up to one month.
- No suspect of malignancy
You may not qualify if:
- NIMV or ICU on admission
- Patient scheduled for procedure (LTX/LVRS) within one month after discharge
- Readmission \<14 days after previous hospitalization
- Significant pathology that would hinder the participation in resistance training (gonarthrosis, arthritis to be judged by the investigator)
- Clinical signs of pulmonary hypertension
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- KU Leuvenlead
Study Sites (1)
Universitair Ziekenhuis Leuven, Campus Gasthuisberg
Leuven, 3000, Belgium
Related Publications (1)
Troosters T, Probst VS, Crul T, Pitta F, Gayan-Ramirez G, Decramer M, Gosselink R. Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010 May 15;181(10):1072-7. doi: 10.1164/rccm.200908-1203OC. Epub 2010 Feb 4.
PMID: 20133927DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 6, 2009
First Posted
April 7, 2009
Study Start
January 1, 2004
Primary Completion
December 1, 2005
Study Completion
December 1, 2008
Last Updated
April 7, 2009
Record last verified: 2009-04